CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

BACKGROUND. Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Goffart, Nicolas, Lombard, Arnaud, Lallemand, François, Kroonen, Jérôme, Nassen, Jessica, Di Valentin, Emmanuel, Berendsen, Sharon, Dedobbeleer, Matthias, Willems, Estelle, Robe, Pierre, Bours, Vincent, Martin, Didier, Martinive, Philippe, Maquet, Pierre, Rogister, Bernard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193023/
https://ncbi.nlm.nih.gov/pubmed/27370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now136
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller